Rossari Biotech Ltd consolidated Q4 FY2026 PAT climbs to Rs. 45.96 crores

Rossari Biotech Limited has reported Consolidated financial results for the period ended March 31, 2026.

Financial Results (Q4 FY2026) - QoQ Comparison

The company has reported total income of Rs. 703.927 crores during the period ended March 31, 2026 as compared to Rs. 582.189 crores during the period ended December 31, 2025.

The company has posted net profit / (loss) of Rs. 45.967 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 32.774 crores for the period ended December 31, 2025.

The company has reported EPS of Rs. 8.29 for the period ended March 31, 2026 as compared to Rs. 5.91 for the period ended December 31, 2025.

Financials	Q4 FY2026	Q3 FY2026	% Change
Total Income	₹ 703.927 crs	₹582.189 crs	20.91%
Net Profit	₹45.967 crs	₹32.774 crs	40.25%
EPS	₹8.29	₹5.91	40.27%

Financial Results (Q4 FY2026) - YoY Comparison

The company has reported total income of Rs. 703.927 crores during the period ended March 31, 2026 as compared to Rs.581.353 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs.45.967 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.34.444 crores for the period ended March 31, 2025.

The company has reported EPS of Rs.8.29 for the period ended March 31, 2026 as compared to Rs.6.21 for the period ended March 31, 2025.

Financials	Q4 FY2026	Q4 FY2025	% Change
Total Income	₹ 703.927 crs	₹581.353 crs	21.08%
Net Profit	₹45.967 crs	₹34.444 crs	33.45%
EPS	₹8.29	₹6.21	33.49%

Financial Results (Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.2418.743 crores during the Financial Year ended March 31, 2026 as compared to Rs.2084.303 crores during the Financial Year ended March 31, 2025.

The company has posted net profit / (loss) of Rs.149.213 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.136.378 crores for the Financial Year ended March 31, 2025.

The company has reported EPS of Rs.26.93 for the Financial Year ended March 31, 2026 as compared to Rs.24.63 for the Financial Year ended March 31, 2025.

Financials	Year Ended FY2026	Year Ended FY2025	% Change
Total Income	₹2418.743 crs	₹2084.303 crs	16.05%
Net Profit	₹149.213 crs	₹136.378 crs	9.41%
EPS	₹26.93	₹24.63	9.34%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 506.15 as compared to the previous close of Rs. 516.20. The total number of shares traded during the day was 11094 in over 678 trades.

The stock hit an intraday high of Rs. 520.00 and intraday low of 497.75. The net turnover during the day was Rs. 5680052.00.

Source : Equity Bulls

Keywords

RossariBiotech Q4FY26 Q4FY2026 FY26 FY2026 ResultUpdate